bioRxiv Science⌕ Search

Biology subjects

Graczer, E.

Publications and source records attributed to Graczer, E..

2 recordsLinked to original sources

Non-muscle actinopathy-associated loss-of-function actin variants modulate cytoskeletal reorganization

Variants in ACTB gene encoding for cytoplasmic {beta}-actin result in a group of rare disorders called non-muscle actinopathies (NMA). We investigated the cellular effects of a missense variant, G302A, and a four-amino-acid deletion, S338-I341, associated with the subgroup of NMA - ACTB pLoF (predicted loss-of-function) disorder in patient-derived fibroblast cells. We found that neither of the mutations affected the organization of actin or the width of the actin-filament bundles, while the mutation G302A reduced the stiffness of the cells as measured by using atomic force microscopy. The latter effect might be associated with the misorganization of tubulin and with the increased size and number of focal adhesions. When we challenged the cells by monolayer stretching and followed the mechanically-induced reorganization of the actin cytoskeleton, we found that G302A mutant cells showed more dense actin filament bundles within the cells compared to wild type cells. At the same time, the extent of cofilin reorganization from the cell periphery was increased upon stretch, and this correlated with an increased cofilin phosphorylation. In the case of the deletion, while the extent of cofilin phosphorylation increased, the extent of reorganization was unaltered; rather, the phosphorylation of myosin light chain, important in counteracting external force, was drastically reduced. We could partially rescue this fascinating effect by overexpressing the active form of the formin mDia. Our findings open the possibility to validate the cellular phenotype in the most affected patients cells, in neurons.

biophysics↗

The Baraitser-Winter Cerebrofrontofacial Syndrome recurrent R196H variant in cytoplasmic β-actin impairs its cellular polymerization and stability

Variants in cytoskeletal actin encoding genes are associated with a broad spectrum of disorders, called non-muscle actinopathies. Among them, Baraitser-Winter cerebrofrontofacial syndrome (BWCFF) displays the most severe symptoms, such as intellectual disability and epilepsy. The exact consequences of the mutation on actins properties, however, are not fully understood. Here we explored the cellular effects of the R196H mutation in patient-derived fibroblasts. We show that the heterozygous mutation causes an actin polymerization defect in cells, leading to a fifty percent decrease in filamentous (F-) actin content. This effect can be rescued by the addition of the actin-polymerizing and stabilizing drug, jasplakinolide. We observed no significant defects either in the organization of the cellular actin cytoskeleton, analyzed by superresolution (STED) microscopy, or in the structure of purified filaments stabilized with phalloidin, explored with atomic force microscopy (AFM). The reduced F-actin content correlated with an approximately fourfold reduction in the stiffness of patient-derived cells probed with AFM. Manipulating the cells by mechanical forces through the application of the Dual Laser Optical Tweezers (DLOT) technique suggests that the mutation weakens the attachment of cytoskeletal actin to the plasma membrane. Inducing dynamical reorganization of actin by uniaxial stretching revealed that the interaction of cofilin with actin is also weakened by the mutation. Based on the existing cofilin-actin structures, the binding of cofilin may weaken the interaction of the neighboring residue E195 with K113, one of the lateral contacts stabilizing the filament. Thus, the mutation possibly exerts its effect through the destabilization of the interfilament interactions, potentially interfering allosterically with cofilin binding during actin depolymerization.

biophysics↗